FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
about
A review on chemical-induced inflammatory bowel disease models in rodentsShining a light on intestinal trafficAn investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation.S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancerSphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetesSphingolipid metabolites in inflammatory disease.Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist.Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.S1P₁ localizes to the colonic vasculature in ulcerative colitis and maintains blood vessel integrity.A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.Transcriptional modulation of SLC26A3 (DRA) by sphingosine-1-phosphate.Targeting T-cell migration in inflammatory bowel disease.Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.Modulation of IL-33/ST2-TIR and TLR signalling pathway by fingolimod and analogues in immune cells.Oxazolone and ethanol induce colitis in non-obese diabetic-severe combined immunodeficiency interleukin-2Rγ(null) mice engrafted with human peripheral blood mononuclear cells.Frontiers in Drug Research and Development for Inflammatory Bowel Disease.Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.NOD-scid IL2R γnull mice engrafted with human peripheral blood mononuclear cells as a model to test therapeutics targeting human signaling pathways.Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans.Sphingosine-1-phosphate: Driver of NFκB and STAT3 persistent activation in chronic intestinal inflammation and colitis-associated cancer.Ablation of ceramide synthase 2 exacerbates dextran sodium sulphate-induced colitis in mice due to increased intestinal permeability.Targeting S1P in Inflammatory bowel disease: new avenues for modulating intestinal leukocyte migration.Accumulation of Mast Cells in the Lesions and Effects of Antiallergic Drugs on the Patients with Inflammatory Bowel Disease
P2860
Q26827500-A998EF36-6EFF-43E3-95B2-C098300A7DC1Q26863227-488F462B-6BE6-4E63-93A7-E8953E071F72Q33392347-5D88CCD0-8096-4AB3-82EB-753EA947CC10Q33857794-5EECA659-4040-4155-A201-10C94703A43FQ33886596-276E813D-B745-40BC-B957-A26FB6133423Q35035148-D1F66308-BF1F-43A0-B005-1015E73E0C6AQ35061720-9976EA2F-3323-429B-8480-8EA917967385Q35535621-2E4062D9-CD03-4A5E-B6F6-0C602E4F81A4Q36211058-C50FBD56-F635-4F17-A4F8-517B3D16032AQ36461786-05641FC9-F2F0-428C-88CD-241C4ABD7422Q36627430-CF70A0A7-7FD1-43DB-9678-FBABE31008A2Q36744155-64F2EC2F-0494-477E-B563-8299AB0C9589Q37061696-07698F19-4D8D-4CD2-9102-5C2E5194CD9BQ37071804-5DFB8321-9AF6-4A39-9A00-387302F20E2FQ38040430-6D891FEE-89CB-4655-9938-1F54329763A7Q38177794-FF675217-CF10-4D5F-8BA3-66ED003A4E1CQ38810636-E9F432DE-3BDA-46FE-92E0-D4220DE5952AQ38957804-BACCAC47-1CBD-4DDE-8BA7-94DE26A0E9A7Q39168573-877B6861-E5C4-4990-A0DE-503E82C2A25DQ39424463-D0FEED9D-185B-4CBF-B522-017968582869Q40953556-9DEDA6D4-B463-4259-A8AF-F32801D58E30Q41768955-5158C145-A79B-4AA8-BC50-76B25E203985Q41979804-74C04658-D93B-4C0A-8D82-0672024E6AABQ41983382-A87531C8-2BE6-4C10-88AB-569E91ED80BBQ47157018-31E573C9-F642-47E3-BCE7-EE1FB8C83DD5Q47725521-E8C6D3B3-0758-4DAA-8F40-41921143641FQ59034926-CAEEC37D-DDDB-443A-BAA4-C800724A0485
P2860
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@ast
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@en
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@nl
type
label
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@ast
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@en
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@nl
prefLabel
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@ast
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@en
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@nl
P2093
P1433
P1476
FTY720 ameliorates oxazolone c ...... ing T helper type 2 functions.
@en
P2093
Carolin Daniel
Gerd Geisslinger
Jurgen M Stein
Nadine Zahn
Nico A Sartory
Ronald Schmidt
P304
P356
10.1016/J.MOLIMM.2007.02.026
P577
2007-05-01T00:00:00Z